Last update Dec. 20, 2022
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Nelfinavir Mesylate; Nelfinavir Mesilate (NFV) in other languages or writings:
Nelfinavir Mesylate; Nelfinavir Mesilate (NFV) belongs to this group or family:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche, España of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is an HIV protease inhibitor with antiviral activity against HIV. It is used in the treatment of HIV infection and AIDS. Oral administration in two - three daily doses.
It is excreted in breast milk in a very small amount, clinically insignificant.. (Weidle 2011, Rezk 2008, Colebunders 2005)
Nearly 5% of infants whose mothers took it had rash, hyperbilirubinemia, or hepatotoxicity. (Minniear 2012)
The plasma levels of these infants were very low or below the limit of detection. (Weidle 2011)
During lactation other HIV/AIDS treatments are preferable. (Panel 2022, WHO 2016)
See below the information of this related product: